Search results
Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
The Janssen Pharmaceutical Companies of Johnson & Johnson | 1,026,074 followers on LinkedIn. At Janssen, we never stop working toward a future where disease is a thing of the past.
Explore the Janssen United States site, and see how we collaborate with partners around the world to make patients healthier.
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 ...
Feb 27, 2021 · Discover 8 facts and things to know about Johnson & Johnson's Janssen COVID-19 vaccine, including how it works and how it might be manufactured and distributed.
4 days ago · Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives.